Investing in Conduit Pharmaceuticals Inc (CDT) might be an excellent idea, but the stock is currently overvalued/undervalued
While Conduit Pharmaceuticals Inc has overperformed by 8.44%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance,